Atrial fibrillation (AFib) is treated through three main strategies: preventing stroke, controlling heart rate, and restoring normal heart rhythm. Most people with AFib use some combination of all three, tailored to their symptoms, age, and other health conditions. The right mix depends on how often episodes occur, how severe they feel, and whether you have other heart problems.
Stroke Prevention Comes First
The most dangerous consequence of AFib isn’t the irregular heartbeat itself. It’s the blood clots that can form when blood pools in the heart’s upper chambers. These clots can travel to the brain and cause a stroke. That’s why stroke prevention is typically the first priority in any AFib treatment plan, even before addressing the rhythm problem.
Your doctor will assess your stroke risk using a scoring system that assigns points for factors like age, high blood pressure, diabetes, prior stroke, and existing heart disease. If your score is 2 or higher, anticoagulant medication (blood thinners) is generally recommended. A score of 1 means anticoagulation may still be worth considering.
For most people, newer oral anticoagulants have largely replaced warfarin as the go-to choice. These newer drugs are at least as effective at preventing strokes and carry a meaningfully lower risk of bleeding inside the brain, with one large analysis finding roughly a sixfold reduction in that specific complication. They’re also more convenient: no regular blood tests, fewer food interactions, and more predictable dosing. That said, the advantage is clearest in relatively healthy patients. In frailer, older individuals with multiple health problems and many medications, the difference between newer drugs and warfarin becomes less consistent.
Left Atrial Appendage Closure
Some people with AFib simply can’t take blood thinners long-term, whether due to a history of serious bleeding, falls, or other medical reasons. For them, a small implanted device offers an alternative. The procedure targets the left atrial appendage, a small pouch in the heart where the vast majority of AFib-related clots form. A plug-like device is threaded through a vein and positioned to seal off this pouch permanently. After the procedure, you’ll typically take antiplatelet medication (similar to aspirin) for several months rather than full anticoagulation for life. This approach is specifically designed for people who need stroke protection but can’t safely stay on blood thinners.
Rate Control: Slowing the Heartbeat
Rate control doesn’t try to fix the irregular rhythm. Instead, it keeps the heart from beating too fast during AFib episodes, which reduces symptoms like pounding, breathlessness, and fatigue. For many people, especially those with mild or tolerable symptoms, this is enough.
The two main drug classes used are beta blockers, which slow the heart rate and reduce the force of contractions, and calcium channel blockers, which relax blood vessels and also slow the rate. Both are taken daily as pills. A third option, digoxin, can help control heart rate at rest but doesn’t work as well during physical activity, so it’s rarely used alone.
The goal is generally to keep the resting heart rate under a comfortable threshold where symptoms improve. Most people find rate control straightforward to manage, though it can take some trial and adjustment to land on the right medication and dose.
Rhythm Control: Restoring Normal Rhythm
Rhythm control aims to get the heart back into its normal, steady pattern and keep it there. This approach tends to provide greater symptom relief and better quality of life than rate control alone, particularly for people who feel significantly limited by their AFib. It involves either medications, procedures, or both.
Antiarrhythmic Medications
Several drugs can help maintain normal rhythm after it’s been restored. Which one your doctor recommends depends heavily on whether you have other heart conditions. For people without structural heart disease, flecainide and propafenone are first-line options. If you have coronary artery disease, sotalol or dronedarone are preferred. For people with heart failure, the choices narrow considerably, and amiodarone becomes the primary option. Amiodarone is the most effective rhythm-control drug available, but it’s generally reserved as a second-line choice for people without heart failure because of its potential for side effects with long-term use, including thyroid, lung, and liver problems.
All antiarrhythmic drugs require monitoring, and finding the right one often involves some patience. None of them work perfectly for everyone, and breakthrough episodes of AFib are common even with medication.
Electrical Cardioversion
Cardioversion is a brief procedure where a controlled electrical shock is delivered to the chest while you’re under short-acting sedation. It resets the heart’s rhythm immediately. About two-thirds of patients convert successfully to normal rhythm during the procedure. The challenge isn’t getting back into rhythm; it’s staying there. Many people eventually slip back into AFib without additional treatment to maintain the result.
Before cardioversion, you’ll need to be on blood thinners for at least four weeks, or have an imaging test to confirm there are no clots in the heart. This precaution is critical because the act of restoring normal rhythm can dislodge an existing clot. The procedure itself takes only minutes, and most people go home the same day.
Catheter Ablation
Ablation is the most definitive rhythm-control option. A thin, flexible tube is guided through a blood vessel into the heart, where it delivers targeted energy (heat or cold) to destroy small areas of tissue that trigger or sustain the abnormal rhythm. The success rate for AFib ablation ranges from 60% to 80%, which is lower than ablation for simpler rhythm problems but still meaningful for many patients.
Recovery is relatively quick. Most people return to desk work within five to seven days and resume exercise after about a week. The full effect takes time, though. During the first three months, you may still experience AFib episodes as the heart tissue heals. This “blanking period” is normal and doesn’t mean the procedure failed. Follow-up visits continue for about a year, and some people need a second ablation if symptoms return.
Ablation is increasingly offered earlier in the course of AFib rather than as a last resort. It’s particularly useful for people whose symptoms don’t respond well to medications, or who prefer a more durable solution over indefinite drug therapy.
Lifestyle Changes That Reduce AFib Burden
Medications and procedures get most of the attention, but lifestyle changes can have a surprisingly large impact on how often AFib occurs and how long episodes last.
Alcohol is one of the clearest triggers. A randomized trial published in the New England Journal of Medicine found that people who drank 10 or more drinks per week and then cut back dramatically saw their AFib recurrence drop from 73% to 53% over six months. The abstinence group also spent far less total time in AFib: a median of 0.5% of monitored time versus significantly more in the group that kept drinking. Even without any other intervention, reducing alcohol led to modest weight loss on its own.
Weight loss has its own independent benefits. Studies show that losing weight can reduce the overall burden of AFib and even reverse some of the structural changes in the heart that perpetuate the condition. The combination of weight management and limiting alcohol to fewer than three drinks per week has shown the most consistent results.
Other lifestyle factors that matter include treating sleep apnea (which is extremely common in people with AFib), managing blood pressure, staying physically active at a moderate level, and reducing caffeine if it’s a personal trigger.
Monitoring After Treatment
Regardless of which treatment path you’re on, tracking your heart rhythm over time helps guide decisions about whether to adjust medications, repeat procedures, or change course. Consumer wearable devices with single-lead ECG capability have become surprisingly accurate for detecting AFib, with studies showing sensitivity ranging from 83% to 100% and specificity from 79% to 100%. These devices won’t replace a formal cardiac monitor, but they can catch episodes between clinic visits and give you and your doctor a more complete picture of how well treatment is working.